{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:37:32Z","timestamp":1793655452205,"version":"4.5.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ovarian cancer is the fifth cause of cancer-related mortality in women, with an expected 5-year survival rate of only 47%. High-grade serous carcinoma (HGSC), an epithelial cancer phenotype, is the most common malignant ovarian cancer. It is known that the precursors of HGSC originate from secretory epithelial cells within the Fallopian tube, which first develops as serous tubal intraepithelial carcinoma (STIC). Here, we used gene editing by CRISPR-Cas9 to knock out the oncogene <jats:italic>p53<\/jats:italic> in dog oviductal epithelia cultured in a dynamic microfluidic chip to create an <jats:italic>in vitro<\/jats:italic> model that recapitulated human STIC. Similar to human STIC, the gene-edited oviduct-on-a-chip, exhibited loss of cell polarization and had reduced ciliation, increased cell atypia and proliferation, with multilayered epithelium, increased <jats:italic>Ki67<\/jats:italic>, <jats:italic>PAX8<\/jats:italic> and <jats:italic>Myc<\/jats:italic> and decreased <jats:italic>PTEN<\/jats:italic> and <jats:italic>RB1<\/jats:italic> mRNA expression. This study provides a biomimetic <jats:italic>in vitro<\/jats:italic> model to study STIC progression and to identify potential biomarkers for early detection of HGSC.<\/jats:p>","DOI":"10.1038\/s41598-020-58507-4","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T11:02:58Z","timestamp":1580468578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["A dog oviduct-on-a-chip model of serous tubal intraepithelial carcinoma"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9896-3459","authenticated-orcid":false,"given":"Marcia","family":"de Almeida Monteiro Melo Ferraz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Beth","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Venzac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Le Gac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nucharin","family":"Songsasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,31]]},"reference":[{"key":"58507_CR1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cell.2016.05.069","volume":"166","author":"H Zhang","year":"2016","unstructured":"Zhang, H. et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell 166, 755\u2013765 (2016).","journal-title":"Cell"},{"key":"58507_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-016-0009-6","volume":"8","author":"SI Labidi-Galy","year":"2017","unstructured":"Labidi-Galy, S. I. et al. High grade serous ovarian carcinomas originate in the fallopian tube. Nat. Commun. 8, 1\u201310 (2017).","journal-title":"Nat. Commun."},{"key":"58507_CR3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc.2016.113","volume":"17","author":"AN Karnezis","year":"2016","unstructured":"Karnezis, A. N., Cho, K. R., Gilks, C. B., Pearce, C. L. & Huntsman, D. G. The disparate origins of ovarian cancers: pathogenesis and prevention strategies. Nat. Rev. Cancer 17, 65\u201374 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"58507_CR4","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1073\/pnas.1017300108","volume":"108","author":"AM Karst","year":"2011","unstructured":"Karst, A. M., Levanon, K. & Drapkin, R. Modeling high-grade serous ovarian carcinogenesis from the fallopian tube. Proc. Natl. Acad. Sci. USA 108, 7547\u20137552 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"58507_CR5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/path.4649","volume":"238","author":"Y Yamamoto","year":"2016","unstructured":"Yamamoto, Y. et al. In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells. J. Pathol. 238, 519\u2013530 (2016).","journal-title":"J. Pathol."},{"key":"58507_CR6","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/modpathol.2011.106","volume":"24","author":"J Li","year":"2011","unstructured":"Li, J. et al. Tubal origin of \u2018ovarian\u2019 low-grade serous carcinoma. Mod. Pathol. 24, 1488\u20131499 (2011).","journal-title":"Mod. Pathol."},{"key":"58507_CR7","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","volume":"25","author":"O Kopper","year":"2019","unstructured":"Kopper, O. et al. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity. Nat. Med. 25, 838\u2013849 (2019).","journal-title":"Nat. Med."},{"key":"58507_CR8","doi-asserted-by":"crossref","unstructured":"Kuhn, E., Tisato, V., Rimondi, E. & Secchiero, P. Current Preclinical Models of Ovarian Cancer. J. Carcinog. Mutagen. 06 (2015).","DOI":"10.4172\/2157-2518.1000220"},{"key":"58507_CR9","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1093\/humrep\/13.11.3114","volume":"13","author":"MT Comer","year":"1998","unstructured":"Comer, M. T., Leese, H. J. & Southgate, J. Induction of a differentiated ciliated cell phenotype in primary cultures of Fallopian tube epithelium. Hum. Reprod. 13, 3114\u201320 (1998).","journal-title":"Hum. Reprod."},{"key":"58507_CR10","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.1117135109","volume":"109","author":"J Kim","year":"2012","unstructured":"Kim, J. et al. High-grade serous ovarian cancer arises from fallopian tube in a mouse model. Proc. Natl. Acad. Sci. 109, 3921\u20133926 (2012).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"58507_CR11","doi-asserted-by":"crossref","unstructured":"Hua, Y. et al. Epithelialization of mouse ovarian tumor cells originating in the fallopian tube stroma. 7.","DOI":"10.18632\/oncotarget.11808"},{"key":"58507_CR12","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1038\/s41388-017-0097-8","volume":"37","author":"A Russo","year":"2018","unstructured":"Russo, A. et al. PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation. Oncogene 37, 1976\u20131990 (2018).","journal-title":"Oncogene"},{"key":"58507_CR13","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1530\/ERC-11-0107","volume":"18","author":"SM King","year":"2011","unstructured":"King, S. M. et al. The impact of ovulation on fallopian tube epithelial cells: Evaluating three hypotheses connecting ovulation and serous ovarian cancer. Endocr. Relat. Cancer 18, 627\u2013642 (2011).","journal-title":"Endocr. Relat. Cancer"},{"key":"58507_CR14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/bjc.2015.471","volume":"114","author":"BS Harrington","year":"2016","unstructured":"Harrington, B. S. et al. Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer. Br. J. Cancer 114, 417\u2013426 (2016).","journal-title":"Br. J. Cancer"},{"key":"58507_CR15","doi-asserted-by":"publisher","unstructured":"House, C. D., Hernandez, L. & Annunziata, C. M. Recent Technological Advances in Using Mouse Models to Study Ovarian Cancer. Front. Oncol., https:\/\/doi.org\/10.3389\/fonc.2014.00026 (2014).","DOI":"10.3389\/fonc.2014.00026"},{"key":"58507_CR16","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/onc.2013.321","volume":"33","author":"E Lengyel","year":"2014","unstructured":"Lengyel, E. et al. Epithelial Ovarian Cancer Experimental Models. Oncogene 33, 3619\u20133633 (2014).","journal-title":"Oncogene"},{"key":"58507_CR17","doi-asserted-by":"publisher","unstructured":"Bobbs, A. S., Cole, J. M. & Dahl, K. D. C. Emerging and Evolving Ovarian Cancer Animal Models. Cancer Growth Metastasis, https:\/\/doi.org\/10.4137\/CGM.S21221 (2015).","DOI":"10.4137\/CGM.S21221"},{"key":"58507_CR18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/path.5065","volume":"245","author":"S Stuckelberger","year":"2018","unstructured":"Stuckelberger, S. & Drapkin, R. Precious GEMMs: emergence of faithful models for ovarian cancer research. J. Pathol. 245, 129\u2013131 (2018).","journal-title":"J. Pathol."},{"key":"58507_CR19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.molmed.2011.02.004","volume":"17","author":"JL Rowell","year":"2011","unstructured":"Rowell, J. L., McCarthy, D. O. & Alvarez, C. E. Dog models of naturally occurring cancer. Trends Mol. Med. 17, 380\u2013388 (2011).","journal-title":"Trends Mol. Med."},{"issue":"1","key":"58507_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ilar\/ilu010","volume":"55","author":"C. E. Alvarez","year":"2014","unstructured":"Alvarez, C. E. Naturally occurring cancers in dogs: Insights for translational genetics and medicine. ILAR J., https:\/\/doi.org\/10.1093\/ilar\/ilu010 (2014).","journal-title":"ILAR Journal"},{"key":"58507_CR21","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/hmg\/5.9.1289","volume":"5","author":"CI Szabo","year":"1996","unstructured":"Szabo, C. I. et al. Human, canine and murine BRCA1 genes: sequence comparison among species. Hum. Mol. Genet. 5, 1289\u201398 (1996).","journal-title":"Hum. Mol. Genet."},{"key":"58507_CR22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1439-0531.2010.01580.x","volume":"45","author":"G Borzacchiello","year":"2010","unstructured":"Borzacchiello, G., Mogavero, S., Tortorella, G., Catone, G. & Russo, M. Expression of Endothelin-1 and Endothelin receptor A in canine ovarian tumours. Reprod. Domest. Anim. 45, 465\u2013468 (2010).","journal-title":"Reprod. Domest. Anim."},{"key":"58507_CR23","doi-asserted-by":"crossref","unstructured":"Lee, C. H. et al. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors. J. Vet. Sci. (Suwon-si, Korea), 200403063 [pii] (2004).","DOI":"10.4142\/jvs.2004.5.1.63"},{"key":"58507_CR24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/vms3.61","volume":"3","author":"K Goebel","year":"2017","unstructured":"Goebel, K. & Merner, N. D. A monograph proposing the use of canine mammary tumours as a model for the study of hereditary breast cancer susceptibility genes in humans. Vet. Med. Sci. 3, 51\u201362 (2017).","journal-title":"Vet. Med. Sci."},{"key":"58507_CR25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1158\/1541-7786.MCR-08-0347","volume":"7","author":"J Zhang","year":"2009","unstructured":"Zhang, J., Chen, X., Kent, M. S., Rodriguez, C. O. & Chen, X. Establishment of a Dog Model for the p53 Family Pathway and Identification of a Novel Isoform of p21 Cyclin-Dependent Kinase Inhibitor. Mol. Cancer Res. 7, 67\u201378 (2009).","journal-title":"Mol. Cancer Res."},{"key":"58507_CR26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/030098588702400607","volume":"24","author":"AK Patnaik","year":"1987","unstructured":"Patnaik, A. K. & Greenlee, P. G. Canine Ovarian Neoplasms: A Clinicopathologic Study of 71 Cases, Including Histology of 12 Granulosa Cell Tumors. Vet. Pathol. 24, 509\u2013514 (1987).","journal-title":"Vet. Pathol."},{"key":"58507_CR27","first-page":"97","volume":"10","author":"R Sapierzy\u0144ski","year":"2007","unstructured":"Sapierzy\u0144ski, R. et al. Tumors of the urogenital system in dogs and cats. Retrospective review of 138 cases. Pol. J. Vet. Sci. 10, 97\u2013103 (2007).","journal-title":"Pol. J. Vet. Sci."},{"issue":"5","key":"58507_CR28","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1177\/1040638711416848","volume":"23","author":"Barbara Banco","year":"2011","unstructured":"Banco, B., Antuofermo, E., Borzacchiello, G., Cossu-Rocca, P. & Grieco, V. Canine ovarian tumors: An immunohistochemical study with HBME-1 antibody. J. Vet. Diagnostic Investig., https:\/\/doi.org\/10.1177\/1040638711416848 (2011).","journal-title":"Journal of Veterinary Diagnostic Investigation"},{"key":"58507_CR29","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1292\/jvms.69.1033","volume":"69","author":"Y Akihara","year":"2007","unstructured":"Akihara, Y. et al. Immunohistochemical evaluation of canine ovarian tumors. J. Vet. Med. Sci. 69, 1033\u20137 (2007).","journal-title":"J. Vet. Med. Sci."},{"key":"58507_CR30","unstructured":"Hermo, G. A., Rimavicius, F. & Gonzalez, D. Tumores del aparato reproductor femenino en caninos y felinos (ovario y utero). Oncoveterinaria 1\u201311 (2017)."},{"key":"58507_CR31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1439-0531.2004.00490.x","volume":"39","author":"N Steinhauer","year":"2004","unstructured":"Steinhauer, N., Boos, A. & G\u00fcnzel-Apel, A. R. Morphological changes and proliferative activity in the oviductal epithelium during hormonally defined stages of the oestrous cycle in the bitch. Reprod. Domest. Anim. 39, 110\u2013119 (2004).","journal-title":"Reprod. Domest. Anim."},{"key":"58507_CR32","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.tcb.2011.09.005","volume":"21","author":"D Huh","year":"2011","unstructured":"Huh, D., Hamilton, G. A. & Ingber, D. E. From 3D cell culture to organs-on-chips. Trends Cell Biol. 21, 745\u2013754 (2011).","journal-title":"Trends Cell Biol."},{"key":"58507_CR33","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nbt.2958","volume":"32","author":"SV Murphy","year":"2014","unstructured":"Murphy, S. V. & Atala, A. 3D bioprinting of tissues and organs. Nat Biotech 32, 773\u2013785 (2014).","journal-title":"Nat Biotech"},{"key":"58507_CR34","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/nprot.2013.137","volume":"8","author":"D Huh","year":"2013","unstructured":"Huh, D. et al. Microfabrication of human organs-on-chips. Nat. Protoc. 8, 2135\u201357 (2013).","journal-title":"Nat. Protoc."},{"key":"58507_CR35","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1039\/C6LC00163G","volume":"16","author":"N Bhattacharjee","year":"2016","unstructured":"Bhattacharjee, N., Urrios, A., Kang, S. & Folch, A. The upcoming 3D-printing revolution in microfluidics. Lab Chip 16, 1720\u20131742 (2016).","journal-title":"Lab Chip"},{"issue":"5","key":"58507_CR36","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1039\/C6LC01566B","volume":"17","author":"Marcia A. M. M. Ferraz","year":"2017","unstructured":"Ferraz, M. A. M. M. et al. Improved bovine embryo production in an oviduct-on-a-chip system: Prevention of poly-spermic fertilization and parthenogenic activation. Lab Chip, https:\/\/doi.org\/10.1039\/C6LC01566B (2017).","journal-title":"Lab on a Chip"},{"key":"58507_CR37","volume":"9","author":"MAMM Ferraz","year":"2018","unstructured":"Ferraz, M. A. M. M. et al. An oviduct-on-a-chip provides an enhanced in vitro environment for zygote genome reprogramming. Nat. Commun. 9, 4934 (2018).","journal-title":"Nat. Commun."},{"key":"58507_CR38","volume":"8","author":"S Xiao","year":"2017","unstructured":"Xiao, S. et al. A microfluidic culture model of the human reproductive tract and 28-day menstrual cycle. Nat. Commun. 8, 14584 (2017).","journal-title":"Nat. Commun."},{"key":"58507_CR39","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nbt.2989","volume":"32","author":"SN Bhatia","year":"2014","unstructured":"Bhatia, S. N. & Ingber, D. E. Microfluidic organs-on-chips. Nat. Biotechnol. 32, 760\u2013772 (2014).","journal-title":"Nat. Biotechnol."},{"key":"58507_CR40","doi-asserted-by":"crossref","first-page":"067001","DOI":"10.1088\/0960-1317\/18\/6\/067001","volume":"18","author":"MA Eddings","year":"2008","unstructured":"Eddings, M. A., Johnson, M. A. & Gale, B. K. Determining the optimal PDMS\u2013PDMS bonding technique for microfluidic devices. J. Micromechanics Microengineering 18, 067001 (2008).","journal-title":"J. Micromechanics Microengineering"},{"key":"58507_CR41","doi-asserted-by":"crossref","unstructured":"Ortega-Prieto, A. M. et al. 3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection. Nat. Commun. 9 (2018).","DOI":"10.1038\/s41467-018-02969-8"},{"key":"58507_CR42","first-page":"1","volume":"8","author":"Y Koo","year":"2018","unstructured":"Koo, Y., Hawkins, B. T. & Yun, Y. Three-dimensional (3D) tetra-culture brain on chip platform for organophosphate toxicity screening. Sci. Rep. 8, 1\u20137 (2018).","journal-title":"Sci. Rep."},{"issue":"7","key":"58507_CR43","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s10439-016-1760-x","volume":"45","author":"Marcia A. M. M. Ferraz","year":"2016","unstructured":"Ferraz, M. A. M. M., Henning, H. H. W., Stout, T. A. E., Vos, P. L. A. M. & Gadella, B. M. Designing 3-Dimensional In Vitro Oviduct Culture Systems to Study Mammalian Fertilization and Embryo Production. Ann. Biomed. Eng., https:\/\/doi.org\/10.1007\/s10439-016-1760-x (2016).","journal-title":"Annals of Biomedical Engineering"},{"key":"58507_CR44","doi-asserted-by":"publisher","unstructured":"Hsiau, T. et al. Inference of CRISPR Edits from Sanger Trace Data., https:\/\/doi.org\/10.1101\/251082.","DOI":"10.1101\/251082"},{"key":"58507_CR45","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10529-016-2064-9","volume":"38","author":"X Yu","year":"2016","unstructured":"Yu, X. et al. Improved delivery of Cas9 protein\/gRNA complexes using lipofectamine CRISPRMAX. Biotechnol. Lett. 38, 919\u2013929 (2016).","journal-title":"Biotechnol. Lett."},{"key":"58507_CR46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/onc.2015.62","volume":"35","author":"SHL George","year":"2016","unstructured":"George, S. H. L. et al. Loss of LKB1 and p53 synergizes to alter fallopian tube epithelial phenotype and high-grade serous tumorigenesis. Oncogene 35, 59\u201368 (2016).","journal-title":"Oncogene"},{"key":"58507_CR47","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.celrep.2017.02.049","volume":"18","author":"NY Wu","year":"2017","unstructured":"Wu, N. Y. et al. Progesterone Prevents High-Grade Serous Ovarian Cancer by Inducing Necroptosis of p53-Defective Fallopian Tube Epithelial Cells. Cell Rep. 18, 2557\u20132565 (2017).","journal-title":"Cell Rep."},{"issue":"5","key":"58507_CR48","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/modpathol.2016.238","volume":"30","author":"Emily E K Meserve","year":"2017","unstructured":"Meserve, E. E. K., Brouwer, J. & Crum, C. P. Serous tubal intraepithelial neoplasia: the concept and its application. Nat. Publ. Gr. 1\u201312, https:\/\/doi.org\/10.1038\/modpathol.2016.238 (2017).","journal-title":"Modern Pathology"},{"issue":"17","key":"58507_CR49","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/onc.2015.288","volume":"35","author":"G Hua","year":"2015","unstructured":"Hua, G. et al. YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells. Oncogene 1\u201319, https:\/\/doi.org\/10.1038\/onc.2015.288 (2015).","journal-title":"Oncogene"},{"key":"58507_CR50","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","volume":"24","author":"R Perets","year":"2013","unstructured":"Perets, R. et al. Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models. Cancer Cell 24, 751\u2013765 (2013).","journal-title":"Cancer Cell"},{"key":"58507_CR51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","volume":"19","author":"CP Crum","year":"2007","unstructured":"Crum, C. P. et al. The distal fallopian tube: A new model for pelvic serous carcinogenesis. Curr. Opin. Obstet. Gynecol. 19, 3\u20139 (2007).","journal-title":"Curr. Opin. Obstet. Gynecol."},{"issue":"1","key":"58507_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","volume":"14","author":"Reid Brett M.","year":"2017","unstructured":"Reid, B. M., Permuth, J. B. & Sellers, T. A. Epidemiology of ovarian cancer: a review., https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2016.0084 (2017).","journal-title":"Cancer Biology & Medicine"},{"issue":"1","key":"58507_CR53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/path.4875","volume":"242","author":"Shiou-Fu Lin","year":"2017","unstructured":"Lin, S.-F., Gerry, E. & Shih, I.-M. Tubal origin of ovarian cancer - the double-edged sword of haemoglobin. J. Pathol., https:\/\/doi.org\/10.1002\/path.4875 (2017).","journal-title":"The Journal of Pathology"},{"key":"58507_CR54","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1021\/ac062118p","volume":"79","author":"BH Chueh","year":"2007","unstructured":"Chueh, B. H. et al. Leakage-free bonding of porous membranes into layered microfluidic array systems. Anal. Chem. 79, 3504\u20138 (2007).","journal-title":"Anal. Chem."},{"key":"58507_CR55","doi-asserted-by":"crossref","first-page":"036504","DOI":"10.1063\/1.4883075","volume":"8","author":"CG Sip","year":"2014","unstructured":"Sip, C. G. & Folch, A. Stable chemical bonding of porous membranes and poly(dimethylsiloxane) devices for long-term cell culture. Biomicrofluidics 8, 036504 (2014).","journal-title":"Biomicrofluidics"},{"key":"58507_CR56","doi-asserted-by":"publisher","unstructured":"Chen, S., Palma-Vera, S. & Langhammer, M. An air-liquid interphase approach for modeling the early embryo-maternal contact zone. Scientific 1\u20137, https:\/\/doi.org\/10.1038\/srep42298 (2017).","DOI":"10.1038\/srep42298"},{"key":"58507_CR57","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.theriogenology.2012.06.010","volume":"78","author":"R Gualtieri","year":"2012","unstructured":"Gualtieri, R. et al. Long-term viability and differentiation of bovine oviductal monolayers: Bidimensional versus three-dimensional culture. Theriogenology 78, 1456\u20131464 (2012).","journal-title":"Theriogenology"},{"key":"58507_CR58","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1290\/0602015.1","volume":"42","author":"M Rajagopal","year":"2006","unstructured":"Rajagopal, M., Tollner, T. L., Finkbeiner, W. E., Cherr, G. N. & Widdicombe, J. H. Differentiated structure and function of primary cultures of monkey oviductal epithelium. Vitr. cell. Dev. Biol. 42, 248\u2013254 (2006).","journal-title":"Vitr. cell. Dev. Biol."},{"key":"58507_CR59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nbt.3081","volume":"33","author":"JA Zuris","year":"2015","unstructured":"Zuris, J. A. et al. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat. Biotechnol. 33, 73\u201380 (2015).","journal-title":"Nat. Biotechnol."},{"key":"58507_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.39030","volume":"7","author":"M Zeng","year":"2018","unstructured":"Zeng, M. et al. Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12\/13. Elife 7, 1\u201320 (2018).","journal-title":"Elife"},{"key":"58507_CR61","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"D Bell","year":"2011","unstructured":"Bell, D. et al. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609\u2013615 (2011).","journal-title":"Nature"},{"key":"58507_CR62","first-page":"1","volume":"4","author":"SHL George","year":"2014","unstructured":"George, S. H. L. & Shaw, P. BRCA and Early Events in the Development of Serous Ovarian Cancer. Front. Oncol. 4, 1\u20138 (2014).","journal-title":"Front. Oncol."},{"key":"58507_CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01217-9","volume":"8","author":"J Ducie","year":"2017","unstructured":"Ducie, J. et al. Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma. Nat. Commun. 8, 1\u20139 (2017).","journal-title":"Nat. Commun."},{"key":"58507_CR64","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","volume":"226","author":"E Kuhn","year":"2012","unstructured":"Kuhn, E. et al. TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions. J. Pathol. 226, 421\u2013426 (2012).","journal-title":"J. Pathol."},{"key":"58507_CR65","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/modpathol.2010.60","volume":"23","author":"AS Sehdev","year":"2010","unstructured":"Sehdev, A. S., Kurman, R. J., Kuhn, E. & Shih, I. M. Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin e and fatty acid synthase. Mod. Pathol. 23, 844\u2013855 (2010).","journal-title":"Mod. Pathol."},{"key":"58507_CR66","doi-asserted-by":"crossref","unstructured":"Laptenko, O., Tong, D. R., Manfredi, J. & Prives, C. The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein. Trends Biochem. Sci. 41 (2016).","DOI":"10.1016\/j.tibs.2016.08.011"},{"key":"58507_CR67","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/0300985810387939","volume":"48","author":"P Rivera","year":"2011","unstructured":"Rivera, P. & von Euler, H. Molecular biological aspects on canine and human mammary tumors. Vet. Pathol. 48, 132\u2013146 (2011).","journal-title":"Vet. Pathol."},{"key":"58507_CR68","first-page":"247","volume":"249","author":"G Borzacchiello","year":"2007","unstructured":"Borzacchiello, G., Russo, V. & Russo, M. Short Communication Immunohistochemical Expression of Cyclooxygenase-2 in Canine Ovarian Carcinomas. 249, 247\u2013249 (2007).","journal-title":"Short Communication Immunohistochemical Expression of Cyclooxygenase-2 in Canine Ovarian Carcinomas."},{"key":"58507_CR69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/rda.12067","volume":"47","author":"N Songsasen","year":"2012","unstructured":"Songsasen, N., Comizzoli, P., Nagashima, J., Fujihara, M. & Wildt, D. The Domestic Dog and Cat as Models for Understanding the Regulation of Ovarian Follicle Development In Vitro. Reprod. Domest. Anim. 47, 13\u201318 (2012).","journal-title":"Reprod. Domest. Anim."},{"key":"58507_CR70","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/mrd.20801","volume":"75","author":"HTAA Van Tol","year":"2008","unstructured":"Van Tol, H. T. A. A., Van Eerdenburg, F. J. C. M. C. M., Colenbrander, B. & Roelen, B. A. J. J. Enhancement of Bovine oocyte maturation by leptin is accompanied by an upregulation in mRNA expression of leptin receptor isoforms in cumulus cells. Mol. Reprod. Dev. 75, 578\u2013587 (2008).","journal-title":"Mol. Reprod. Dev."}],"updated-by":[{"DOI":"10.1038\/s41598-020-61782-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58507-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58507-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58507-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:36:48Z","timestamp":1670308608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58507-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,31]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["58507"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-58507-4","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-020-61782-w","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,31]]},"assertion":[{"value":"11 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1575"}}